Market Tracker

12/19 11:01pm ET

Novogen Ltd (NASDAQ:NVGN)

2.58
Data as of Dec 19
 -0.15 / -5.49%
Today’s Change
1.51
Today|||52-Week Range
5.97
-40.00%
Year-to-Date

Today’s Trading

Previous close2.73
Today’s open2.56
Day’s range2.43 - 2.97
Volume1,402,581
Average volume (3 months)433,235
Market cap$17.4M
Dividend yield--
Data as of 4:00pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)+18.36%
Earnings growth (this year)--
Earnings growth (next 5 years)+4.00%
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book14.24

Competitors

 Today’s
change
Today’s
% change
DARADARA BioSciences Inc+0.04+4.30%
OMBPOmni Bio Pharmaceuti...+0.05+12.82%
CPHIChina Pharma Holding...-0.04-8.33%
RGDXResponse Genetics In...-0.01-1.15%
Data as of 4:04pm ET, 12/19/2014

Financials

Next reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$0.00
Annual profit (last year)-$6.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Executive Chairman &
Chief Executive Officer
Graham Edmund Kelly
Chief Financial Officer &
Non-Executive Director
Steven Coffey
Corporate headquarters
Hornsby, New South Wales (nsw)

Forecasts